Literature DB >> 991534

Enhanced phenacetin metabolism in human subjects fed charcoal-broiled beef.

A H Conney, E J Pantuck, K C Hsiao, W A Garland, K E Anderson, A P Alvares, A Kappas.   

Abstract

There were marked individual differences in the plasma levels of phenacetin after oral administration of a 900-mg dose to 9 normal volunteers eating customary home diet. Feeding a diet that contained charcoal-broiled beef for 4 days prior to the administration of phenacetin markedly decreased the plasma levels of this drug without appreciably influencing the plasma concentrations of phenacetin's metabolite, N-acetyl-p-aminophenol (APAP), or the plasma half-life of phenacetin. The average peak concentration of phenacetin in plasma, after a 900-mg oral dose, fell from 1,628 ng/ml, when the subjects were fed a control diet for 7 days, to 352 ng/ml after they were fed the same diet which contained charcoal-broiled beef for 4 days. The average peak concentration of phenacetin rose to 1,885 ng/ml after the subjects were subsequently fed the control diet for 7 days. The ratios of the average concentrations of APAP in plasma to those of phenacetin markedly increased after the charcoal-broiled beef diet. The results suggest that a diet containing charcoal-broiled beef enhances the metabolism of phenacetin in the gastrointestinal tract and/or during its first pass through the liver. This effect greatly decreases the bioavailability of phenacetin.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 991534     DOI: 10.1002/cpt1976206633

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  35 in total

Review 1.  Dietary effects on drug metabolism and transport.

Authors:  Robert Z Harris; Graham R Jang; Shirley Tsunoda
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 2.  Research review. Interactions between environmental chemicals and drug biotransformation in man.

Authors:  A P Alvares
Journal:  Clin Pharmacokinet       Date:  1978 Nov-Dec       Impact factor: 6.447

3.  Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines.

Authors:  M A Butler; M Iwasaki; F P Guengerich; F F Kadlubar
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

4.  Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans.

Authors:  Roza Ghotbi; Magnus Christensen; Hyung-Keun Roh; Magnus Ingelman-Sundberg; Eleni Aklillu; Leif Bertilsson
Journal:  Eur J Clin Pharmacol       Date:  2007-03-17       Impact factor: 2.953

5.  The effect of dietary energy and protein deficiency on drug metabolism.

Authors:  O Hamberg; L Ovesen; A Dorfeldt; S Loft; J Sonne
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 6.  The influence of food on the absorption and metabolism of drugs: an update.

Authors:  L Williams; D P Hill; J A Davis; D T Lowenthal
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Jul-Sep       Impact factor: 2.441

7.  Liver function in physically trained subjects: galactose elimination capacity, plasma disappearance of indocyanine green, and aminopyrine metabolism in long-distance runners.

Authors:  J J Ducry; H Howald; T Zysset; J Bircher
Journal:  Dig Dis Sci       Date:  1979-03       Impact factor: 3.199

8.  Drug metabolism by the gastrointestinal mucosa.

Authors:  C F George
Journal:  Clin Pharmacokinet       Date:  1981 Jul-Aug       Impact factor: 6.447

9.  Dietary influences on the kinetics of antipyrine and aminopyrine in human subjects.

Authors:  K Krishnaswamy; R Kalamegham; N A Naidu
Journal:  Br J Clin Pharmacol       Date:  1984-02       Impact factor: 4.335

10.  Pyrolysis products from amino acids and protein: highest mutagenicity requires cytochrome P1-450.

Authors:  D W Nebert; S W Bigelow; A B Okey; T Yahagi; Y Mori; M Nagao; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.